Delek US director granted 3,436 DK shares
Delek US Holdings, Inc. director Ezra Uzi Yemin reported a compensation-related stock grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Delek US Holdings, Inc. director Ezra Uzi Yemin reported a compensation-related stock grant. He received 3,436 shares of common stock on June 10, 2026 at $48.01 per share, classified as a grant or award rather than an open-market purchase.
Following this grant, Yemin directly owns 213,717 common shares. He also has an indirect position of 447,795 common shares held through Yemin Investments, LP. The filing shows an acquisition of shares, not a sale or disposition.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,436 | $48.01 | $165K |
| holding | Common Stock | -- | -- | -- |
Key Figures
Key Terms
grant/award acquisition financial
Common Stock financial
indirect ownership financial
transaction code A financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Ezra Uzi Yemin report in this Delek US (DK) Form 4 filing?
Was the Delek US (DK) Form 4 transaction an open-market purchase or a grant?
Did the Delek US (DK) Form 4 show any insider sales by Ezra Uzi Yemin?
AI-generated analysis. How Rhea-AI works. Not financial advice.